首頁 › 癌症（所有類型） › 加州 › San Diego
San Diego, CA 的 癌症（所有類型） 臨床試驗
32 項針對 癌症（所有類型） 的研究正在 San Diego（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
招募中2/3 期
- UC San Diego Health - Moores Cancer Center /ID# 278836, La Jolla · 距離 11 英里
A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)
招募中1/2 期
- GSK Investigational Site, La Jolla · 距離 11 英里
A Study of PHN-012 in Patients With Advanced Solid Tumors
招募中1 期
- PHN-012-001 Site, San Diego
Registry Study for Radiation Therapy Outcomes
招募中觀察性研究
- California Protons Cancer Therapy Center, San Diego
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
招募中觀察性研究
- University of California San Diego, La Jolla · 距離 11 英里
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
招募中2/3 期
- UC San Diego Medical Center - Bankers Hill, San Diego
- UC San Diego McGrath Outpatient Pavilion - Hillcrest, San Diego
- UC San Diego Medical Center - Hillcrest, San Diego
- 還有 5 項
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
招募中3 期
- University of California, San Diego Moores Cancer Center, La Jolla · 距離 11 英里
Intratumoral N17350 in Advanced Solid Tumors
招募中1/2 期
- Scripps Clinic Torrey Pines - La Jolla, San Diego
Prospective Study to Assess a Diagnostic Aid for Cancer
招募中觀察性研究
- South Coast Gynecologic Oncology, San Diego
- Southern California Research Center, Coronado · 距離 2 英里
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
招募中2/3 期
- University Of California San Diego Moores Cancer Center, La Jolla · 距離 11 英里
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
招募中2 期
- Kadima Neuropsychiatry Institute, San Diego
A Phase 1/1b Study of IAM1363 in HER2 Cancers
招募中1 期
- UCSD Moores Cancer Center, La Jolla · 距離 11 英里
UCSD Image-Guided Cognitive-Sparing Radiosurgery for Intracranial Lesions
招募中2 期
- Moores Cancer Center, San Diego
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
招募中3 期
- UC San Diego, San Diego
Project: Every Child for Younger Patients With Cancer
招募中觀察性研究
- Rady Children's Hospital - San Diego, San Diego
- Naval Medical Center -San Diego, San Diego
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
招募中3 期
- Kaiser Permanente-San Diego Zion, San Diego
- UC San Diego Moores Cancer Center, La Jolla · 距離 11 英里
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
招募中1 期
- Moores Cancer Center, La Jolla · 距離 11 英里
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
招募中1/2 期
- University of California, San Diego Moores Cancer Center, San Diego
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
招募中
- VA San Diego Healthcare System, San Diego, CA, San Diego
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
招募中1/2 期
- UCSD Moores Cancer Center, La Jolla · 距離 11 英里
Multisite Implementation of COMPRENDO
招募中歡迎健康志工
- Rady Children's Hospital San Diego/University of California San Diego Moores Cancer Center, San Diego
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
招募中2 期
- University of California San Diego, La Jolla · 距離 11 英里
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
招募中2 期
- University of California San Diego Moores Cancer Center, La Jolla · 距離 11 英里
Study of Personalized Cancer Therapy to Determine Response and Toxicity
招募中觀察性研究
- Rady Children's Hospital, San Diego, San Diego
- UCSD Moores Cancer Center, La Jolla · 距離 11 英里
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
招募中2 期
- Moores Cancer Center at UC San Diego /ID# 230157, La Jolla · 距離 11 英里
Beat Childhood Cancer Specimen Banking and Data Registry
招募中觀察性研究歡迎健康志工
- Rady Children's Hospital, San Diego
Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients
招募中3 期
- Rady Children's Hospital San Diego, San Diego
- University of California San Diego, La Jolla · 距離 11 英里
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, La Jolla · 距離 11 英里
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
招募中1/2 期
- UCSD Moores Cancer Center, La Jolla · 距離 11 英里
A Beta-only IL-2 ImmunoTherapY Study
招募中1/2 期
- Sharp Memorial Hospital, San Diego
Cardiotoxicity Assessment Through Comprehensive Heart Imaging to Predict Heart Failure
招募中觀察性研究
- Rady Children's Hospital, San Diego
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
招募中3 期
- Moores Cancer Center - UCSD Health, La Jolla · 距離 11 英里
其他城市的 癌症（所有類型） 試驗
- Houston, TX121 項研究
- New York City, NY109 項研究
- Boston, MA85 項研究
- Los Angeles, CA74 項研究
- Nashville, TN65 項研究
- Philadelphia, PA59 項研究
- Washington, DC58 項研究
- Durham, NC58 項研究
- Chicago, IL51 項研究
- Atlanta, GA49 項研究
- Seattle, WA49 項研究
- Arlington, VA48 項研究
San Diego 的其他研究
- 非小細胞肺癌48 項研究
- 乳癌41 項研究
- 前列腺癌31 項研究
- 轉移性癌症30 項研究
- 大腸直腸癌25 項研究
- 卵巢癌24 項研究
- 胰臟癌24 項研究
- 肺癌23 項研究
- 肥胖症23 項研究
- 心臟衰竭23 項研究
- 憂鬱症21 項研究
- 黑色素瘤18 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。